Is Progressive Supranuclear Palsy hereditary?

Progressive Supranuclear Palsy (PSP) is generally considered a sporadic condition rather than a hereditary disease, meaning it is not typically passed down through families in a direct, predictable Mendelian pattern.

Understanding Genetic Risk

In clinical genetics, we distinguish between a "genetic" disease (caused by changes in DNA) and a "hereditary" disease (passed from parent to child). Progressive Supranuclear Palsy is associated with genetic variations, particularly in the MAPT gene on chromosome 17, which encodes the tau protein. However, these variations are considered risk factors rather than direct causes. Most cases of Progressive Supranuclear Palsy occur in individuals with no family history, suggesting a multifactorial etiology involving a complex interplay between genetics, environmental triggers, and aging.

Inheritance and Risk

Because Progressive Supranuclear Palsy is not inherited in a simple autosomal dominant or recessive manner, we cannot assign a specific percentage risk to the children of an affected parent. Familial cases are extremely rare, and when they do occur, they do not follow a clear, single-gene inheritance pattern. Consequently, de novo or spontaneous mutations are not the standard explanation for the onset of the disease; rather, it is viewed as a neurodegenerative process that emerges later in life.

Genetic Counseling and Testing

Routine genetic testing is not currently recommended for the diagnosis of Progressive Supranuclear Palsy, as the diagnosis remains a clinical one based on the characteristic symptoms like vertical gaze palsy and postural instability. Because there is no reliable genetic test to predict the development of the condition, prenatal diagnosis and carrier testing are not standard clinical practices. For families concerned about a rare history of multiple affected relatives, genetic counseling can be beneficial to review the family pedigree and provide emotional support, though it rarely changes the clinical management of the patient.

Medical Disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your neurologist or a qualified genetic counselor regarding your specific medical condition or family history.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• CurePSP (Foundation for PSP/CBD and Related Brain Diseases)


• Online Mendelian Inheritance in Man (OMIM)


• Orphanet: The portal for rare diseases and orphan drugs